期刊文献+

同型半胱氨酸在2型糖尿病合并视网膜病变患者中的表达及相关性探讨

The relationship between homocysteine expression and diabetic retinopathy in patients with type 2 diabetes
原文传递
导出
摘要 目的:探讨血清同型半胱氨酸(Hcy)表达与2型糖尿病(T2DM)患者视网膜病变是否有相关性。方法选择79例 T2DM患者,根据视网膜病变程度分为增殖期糖尿病视网膜病变(DR)组26例,背景期DR 组25例,糖尿病无视网膜病变组28例,另选择同期健康体检者28例作为对照组。检测比较各组人群血糖值、Hcy,分析其临床意义。结果对照组、糖尿病无视网膜病变组、背景期 DR 组、增殖期 DR 组 FPG、Hcy呈递增趋势,差异均有统计学意义(F =448.53、174.25,均 P <0.01),组间比较可见对照组 FPG 为(4.86±0.42)mmol/L,明显低于背景期 DR 组的(8.73±0.48)mmol/L(t =31.59,P <0.01)及增值期 DR 组的(10.9±0.95)mmol/L(t =30.59,P <0.01),增殖期 DR 亦明显高于糖尿病无视网膜病变组(t =17.72,P <0.01)。Hcy组间比较可见对照组 Hcy 水平为(7.93±0.70)μmol/L,明显低于背景期 DR 组的(9.45±0.83)μmol/L(t =7.69,P <0.01),及增殖期 DR 组的(13.55±1.56)μmol/L(t =11.02,P <0.01),增殖期 DR 亦明显高于糖尿病无视网膜病变组(t =12.52,P <0.01)。结论Hcy 可能参与了2型糖尿病合并视网膜病变的过程,有可能作为视网膜病变程度的重要参考指标。 Objective To explore the relationship between homocysteine (Hcy)expression and diabetic ret-inopathy(DR)in patients with type 2 diabetes mellitus (T2DM).Methods 79 patients with T2DM were selected and divided into proliferative DR group (n =26),background stage of DR group (n =25)and without DR group(n =28)according to the degree of retinopathy.28 cases of healthy physical examination were involved as control group. Blood glucose levels,Hcy and clinical significance were detected and compared among the groups.Results The FPG and Hcy levels in the control group,without retinopathy group,background stage of DR group and proliferative DR group showed an increasing trend,there were significant differences among groups (F =448.53,174.25,all P 〈0.01).The FPG level of the control group was (4.86 ±0.42)mmol/L,which was significantly lower than the back-ground stage of DR group[(8.73 ±0.48)mmol/L,t =31.59,P 〈0.01 ]and the proliferative DR group[(10.9 ± 0.95)mmol/L,t =30.59,P 〈0.01].The FPG level of proliferative diabetic retinopathy DR group was also signifi-cantly higher than without retinopathy group(t =17.72,P 〈0.01).The Hcy level of the control group was (7.93 ± 0.70)μmol/L,which was significantly lower than the background stage of DR group[(9.45 ±0.83)μmol/L,t =7.69,P 〈0.01]and the proliferative DR group[(13.55 ±1.56)μmol/L,t =11.0,P 〈0.01].The Hcy level of the proliferative DR group was also significantly higher than without retinopathy group(t =12.52,P 〈0.01).Conclusion Hcy may involved in the process of T2DMwith DR,it may be used as an important reference index for the degree of retinopathy.
作者 鲍红丹
出处 《中国基层医药》 CAS 2016年第14期2155-2157,共3页 Chinese Journal of Primary Medicine and Pharmacy
关键词 糖尿病 2 高同种半胱氨酸血症 糖尿病视网膜病变 Diabetes mellitus,type 2 Hyperhomocysteinemia Diabetic retinopathy
  • 相关文献

参考文献14

  • 1Zheng Y, He M, Congdon N. The worldwide epidemic of diabetic retinopathy [ J ]. Indian Jou~al of Ophthalmology, 2012,60 ( 5 ) : 428-431. DOI : 10. 4103/0301-4738. 100542.
  • 2Ejaz S, Chekarova I, Ejaz A, et al. Importance of pericytes and mechanisms of pericyte loss during diabetie retinopathy [J]. Dia- betes Obesity & Metabolism,2008,10 ( 1 ) :53-63. D OI : 10.1111/ j. 1463-1326. 2007. 00795. x.
  • 3惠延年,王琳.糖尿病视网膜病变和糖尿病黄斑水肿的国际临床分类法[J].中华医学信息导报,2004(10):16-16. 被引量:6
  • 4Katulanda P, Ranasinghe P, Jayawardena R. Prevalence of reti-nopathy among adults with self-reported diabetes mellitus:the Sri Lanka diabetes and Cardiovascular Study [ J ]. BMC Ophthalmol, 2014,14 ( 3 ) : 1-8. DOI : 10.1186/1471-2415-14-100.
  • 5Ju YY, Na KK, Yun JL, et al. Prevalence and factors associated with diabetic retinopathy in a Korean adult population:the 2008 - 2009 Korea National Health and Nutrition Examination Survey [ J ]. Diabetes Res Clin Pract,2013,102 ( 3 ) : 218-224. DOI : 10. 1016/j. diabres. 2013.10. 016.
  • 6He BB, Wei L, Gu Y J, et al. Factors associated with diabetic reti- nopathy in chinese patients with type 2 diabetes mellitus[J]. Int J Endocrinol, 2012, 2012 ( 1 ) : 74-82. DOI: 10. 1155/2012/ 157940.
  • 7Rani PK, Raman RA. Risk factors for diabetic retinopathy in self- reported rural population with diabetes [ J ]. J Postgraduate Med, 2009,55 ( 2 ) :92-96. DOI: 10. 4103/0022-3859. 48787.
  • 8尤巧英,俞利红.影响2型糖尿病视网膜病变进展的相关危险因素研究[J].中国慢性病预防与控制,2014,22(4):411-413. 被引量:10
  • 9Crosby-Nwaobi R, Chatziralli I, Sergentanis T, et al. Cross talk be- tween lipid metabolism and inflammatory markers in patients with diabetic retinopathy[ J]. J Diabet Res ,2015,2015 : 191382. DOI : 10. 1155/2015/191382.
  • 10Lin JC, Shau WY, Lai MS. Long-acting insulin analogues and dia- betic retinopathy: a retrospective cohort study [ J]. Clin Ther, 2014,36(9 ) : 1255-1268. DOI: 10. 1016/j. clinthera. 2014.06. 031.

二级参考文献29

  • 1杨怀芹,李娜.高同型半胱氨酸血症与脑卒中的关系及临床意义(附106例临床观察)[J].中国全科医学,2005,8(3):236-237. 被引量:26
  • 2朱锋,张哲,李红.血尿酸:2型糖尿病视网膜病变的独立危险因素[J].浙江医学,2005,27(4):266-268. 被引量:16
  • 3Nakajima M, Cooney M J, Tu AH, Chang KY, Cao J, Ando A, et al. Normalization of retinal vascular permeability in experimen- tal diabetes with genistein[ J]. Invest Ophthalmol Vis Sci,2001, 42(9) :2110-2114.
  • 4Seshadri N, Robinson K. Homocysteme, B vitamins, and coro- nary artery disease[ J]. Med Clin North Am,2000,84 ( 1 ) :215- 237.
  • 5Montalescot G, Ankri A, Chadefaux-Vekemans B, Blacher J, Philippe F, Drobinski G, et al. Plasma homocysteine and the ex- tent of athero- sclerosis in patients with coronary artery disease [ J ]. Intern J Cardiol, 1997,50 ( 3 ) :295-300.
  • 6Hoogeveen EK, Kostense P J, Eysink PE, Polak BC, Beks P J, Ja- kobs C, et al. Hyperhomocysteinemia is associated with the presence of retinopathy in type 2 diabetes mellims: the Hoorn study[ J]. Arch Intern Med ,2000,160 ( 19 ) :2984-2990.
  • 7Au-Yeung KK, Woo CW, Sung FL, Yip JC, Siow YL. Hyperhomo- cysteinemia activates nuclear factor-kappa B in endothelial cells via oxidative stress[ J]. Circulat Res ,2004,94( 1 ) :28-36.
  • 8Dawson H, Collins G, Pyle R, Deep-Dixit V, Taub DD. The im- munoregulatory effects of homocysteine and its intermediates on T-lymphocyte function[ J]. Mech Ageing Dev, 2004,125 (2) : 107-110.
  • 9Koh JY, Choi DW. Quantitative determination of glutamate medi- ated cortical neuronal injury in cell culture by lactate dehydro- genase effiux assay[J]. JNeurosci Methods, 1987,20( 1 ) :83-90.
  • 10de la Cruz JP, Gonzalez-Correa JA, Guerrero A, de la Cuesta FS. Pharmacological approach to diabetic retinopathy [ J ]. Diabetes Metab Res Rev.2004.20(2) ,91-113.

共引文献28

相关作者

内容加载中请稍等...

相关机构

内容加载中请稍等...

相关主题

内容加载中请稍等...

浏览历史

内容加载中请稍等...
;
使用帮助 返回顶部